SlideShare a Scribd company logo
JFIM 2015
« Difficult » tumours of the
Liver
Yves Menu
Is it…
§ The rare form of a common disease?
§ The common form of a rare disease ?
Metastases
HCC
CCC
Angioma
FNH
Adenoma
Hepatocholangiocarcinoma
Angiosarcoma
Lymphoma
Short list of solid liver masses
Angiomyolipoma Hematoma
Metastases
HCC
CCC
Angioma
FNH
Adenoma
HepatocholangiocarcinomaAngiosarcoma
Lymphoma
Which ones require a treatment?
Angiomyolipoma Hematoma
Metastases
HCCCCC
Angioma
FNH
Adenoma
Hepatocholangiocarcinoma
Angiosarcoma
Lymphoma
Which ones are common?
Angiomyolipoma Hematoma
Metastases
HCCCCC
Angioma
FNH
Adenoma
Hepatocholangiocarcinoma
Angiosarcoma
Lymphoma
Common AND require a treatment
Angiomyolipoma Hematoma
Metastases
HCC
CCC
Angioma
FNH
Adenoma
HepatocholangiocarcinomaAngiosarcoma
Lymphoma
Rare but potentially recognizable with imaging
Angiomyolipoma Hematoma
Let’s adapt to modern Life Style
Let’s adapt to modern Life Style
LECTURE
AVAILABLE HERE!
The clue is elsewhere
The Mixed Grill
The Alien
How to be brilliant
Be patient
How to look stupid
Your best friend is…
The Mixed-Grill
§ A 68 yo man, with metabolic chronic liver disease (NASH), A
focal liver lesion is found at US.
§ CT is performed, with arterial and portal phase.
Artériel
Artériel
What is the reason for asymetry of
liver enhancement at the arterial
phase ?
1.  Tumour angiogenesis increases regional perfusion («liver
mismatch »)
2.  Hypoenhancement of the left lobe
3.  Portal flow problem
4.  Hepatic vein problem
5.  Arterialization of the right liver lobe, related to chronic liver
disease
Portal Phase
According to mRECIST, in case of HCC, coeliac or
mesenteric lymph node is a measurable target if its
small axis is
1.  ≥ 10 mm
2.  ≥ 15 mm
3.  ≥ 20 mm
4.  ≥ 25 mm
According to mRECIST, in case of HCC, porta
hepatis lymph node is a measurable target if its
small axis is
1.  ≥ 10 mm
2.  ≥ 15 mm
3.  ≥ 20 mm
4.  ≥ 25 mm
Finally…
§ Ill-defined mass, with necrosis, portal vein
invasion, satellite nodules and loco regional
Lymph Nodes
§ In a patient with chronic liver disease
Which is the tumour that never invades the portal
vein?
1.  HCC
2.  Cholangiocarcinoma
3.  Liver Mets
4.  Neuroendocrine tumour
5.  Hepatocholangiocarcinoma
Which is the tumour that never invades the portal
vein?
1.  HCC
2.  Cholangiocarcinoma
3.  Liver Mets
4.  Neuroendocrine tumour
5.  Hepatocholangiocarcinoma
The most likely diagnosis is HCC,
however:
§ Total absence of hypervascularization
§ TIP : although 20% of HCC are hypovascular, they are
usually not necrotic also
§ AFP basse
Hypovascular + Necrosis + Cirrhosis = Weird !
Strategy
§ Most likely diagnosis?
§  HCC on cirrhosis
§ Which is the best treatment?
§  Surgery
§ Is it possible?
< Good status, no Portal Hypertension, left liver normal, no distant
lesion
= Infiltrating tumour, portal envasion, lymph nodes
§ Decision
§  Right hepatectomy
J30
Hepato-Cholangiocarcinoma
§ Not so rare : 1-5 % of liver primary malignancies
§ H>F, chronic liver disease
§ Poor prognosis: 5-y survival 18-24%, including resected
cases
§ Diagnosis mainly rely on histology and immunohistology
§  Mucus +
§  DesmoplasticStroma
§  Fibrosis + nécrosis + haemorrhage
§  CK7/CK19 +
§ The biopsy may miss the Cholangiocellular compartment
18 M3 M
Usual appearance of a rare tumour
§ In a patient with chronic liver disease, absence of
hypervascularization associated to extensive necrosis would
be unusual for HCC
§ Consider Heaptocholangiocarcinoma. Biopsy will not help
The Alien..
§ A 64 yo man, with end-stage HBV cirrhosis. During the pre
transplantation staging, US finds a 30 mm hypoechoic mass
§ MRI is performed in order to characterize and stage
T2 T1 FS
T1 Arterial Phase DWI
What is the most likely diagnosis?
A.  Low grade Dysplastic Nodule
B.  High grade Dysplastic Nodule
C.  Regeneration Macronodule
D.  HCC
Nodule in the Nodule
What is the most likely diagnosis?
A.  Low grade Dysplastic Nodule
B.  High grade Dysplastic Nodule
C.  Regeneration Macronodule
D.  HCC
Dysplastic Nodules (DN)
§ Easy to recognize features
§  Hyper T1
§  No fat
§  Iso or Hypo T2
§  No arterial enhancement
§  Precursor of HCC (high grade)
§ However
§  Only the minority of DN’s are typical à iceberg syndrome
§  HCC will come, but you don’t know where…
§ The Nodule-in-the-Nodule
§  Famous and pathognomonic, but rare
2009
2009
08/2012
Be patient!
§ A 53 yo man comes with abnormal liver tests
§ Diagnosis of HCV is established
§  US shows a large mass in the liver
In Out
T1 FS
T2
ADC
DWI
DWI
Liver contour
Biopsy :
-  Cirrhosis
-  Adenocarcinoma most likely related to intestinal pimary cancer
Cytokeratins (CK)
CK7 - CK7 +
CK20 -
CK20 +
Cytokeratins
filaments
CK are couples
Basic
1 à 8
Acid
9 à 20
Cytokeratin (CK)
CK7 - CK7 +
CK20 - HCC Cholangiocarcinoma
CK20 + Colorectal Ca Pancreatic Ca
In this patient: CK7+/CK20-
Peripheral Cholangiocarcinoma (1
answer is correct):
A.  Is more common on a cirrhotic liver
B.  Usually comes with dilatation of bile ducts
C.  Due to fibrous stroma (unlike HCC), capsular
retraction and delayed enhancement are
pathognomonic features.
Peripheral Cholangiocarcinoma (1
answer is correct):
A.  Is more common on a cirrhotic liver
B.  Usually comes with dilatation of bile ducts
C.  Due to fibrous stroma (unlike HCC), capsular
retraction and delayed enhancement are
pathognomonic features.
Peripheral Cholangiocarcinoma (1
answer is correct):
A.  Is more common on a cirrhotic liver
B.  Usually comes with dilatation of bile ducts
C.  Due to fibrous stroma (unlike HCC), capsular
retraction and delayed enhancement are
pathognomonic features.
Cholangiocarcinoma (CC)
§  Second more common liver primary malignancy
§  Relative risk is x2 in cirrhotic patients
§  Usual features are:
§  Lobulated mass
§  Hypodense centre (necrosis ou mucus)
§  Mild arterial enhancement
§  Late enhancement (fibrous compartment), non specific
§  Capsular rretraction (20%, non specific)
§  Bile ducts dilatation (20%)
§  Curative treatment is surgery
§  Standard CT is GEMOX (GEMcitabine + OXaliplatine)
§  Poor prognosis in general, however, the doubling time has to be
evaluated as prolonged survival (> 3 years) is sometimes observed
In a cirrhotic patient, delayed enhancement is strongly in favour of a CCC, as
HCC never presents with such a feature
In a non – cirrhotic patient, be careful, as mets may have the same behaviour
01/2014 (7 m)
Your best friend is…
§ A 62 yo woman, with a previous liver transplantation,
presents with abnormal liver tests.
§ MRI is performed to rule out biliary complication.
§ The radiologist report says that there is a « colon artefact
within the liver »
In Out
Fat Sat MPR
Plain Arterial
Portal 4’
DWI
ADC Map
ADC=1,29
b=0 b=200 b=800
What is white on T1?
§ Fat
§ Blood
§ Proteins
§ And….
Fat Sat
b=800
Your best friend is …
Ultrasound !
Finally….
§ Stones and calcifications are occasionnally white on T1
12 Days after OLT
Plain Arterial
Portal
Liver infarction post OLT
28-12-2012
06-03-2013
29-01-2013
The clue is elsewhere
§ A 44 yo woman with severe bipolar disorder and recently
discovered neurosarcoidosis. She is heavily depressed.
§ She complains of dyspnea and cough. Plain CT of the chest
is performed in order to find pulmonary lesions, which is
present.
§ An abnormality in the liver is found, and contrast enhanced
images are obtained. There are no abdominal symptoms,
liver tests are normal excepting for a mild increase of
transaminases
Summary
§ Multiple masses
§ Faintly vascular
§ In the context of sarcoidosis
§ However clinically asymptomatic
Strategy
§ Rule out sarcoidosis (no spleen lesion, nodular liver lesions)
§ Further step(s) ?
§  Biopsy à Denied by the patient
§  PET-CT à Normal
Something has to be done and it is free…
1 m after surgery 10 m after surgery
Summary
§ Half of GastroEnteroPancreatic NeuroEndocrine Tumours
(GEP-NET) are fortuitously discovered on imaging
§ Discordance between patient’s good condition and advanced
imaging findings is a target sign
§ Don’t expect to rule out GEP-NET if not hypervascularized
§ FDG PET-CT might be negative in well-differentiated lesions
(50%)
§ Don’t forget to look for « hidden areas »
§ DWI is usually the most powerful sequence for detection
How to be brilliant…
§ A 75 YO man, with a cirrhosis on NASH. A nodule is found in
the liver at Ultrasound
Angiosarcoma
§ Liver angiosarcoma occurs mainly in the elder
§ Third most common primary liver maligancies
§ The prognosis of liver angiosarcoma is very poor with almost
all patients with this kind of disease die within 2 years after
diagnosis
§  Early metastases to other organs, such as lung, spleen, or bone
§  Severe intra-abdominal hemorrhage due to spontaneous rupture
§ Remember the dotted enhancement, translating “peliosis-
like” blood-filled cavities
How to look stupid
§ A 45 yo man with alcohol abuse and abnormal liver tests. US
finds a hypoechic 2 cm mass in the right liver lobe
Hypervascular
Nodule
Portal Phase
Homogenization
Segmental
hypervascularization
Arterio-Portal Fistula
hypervascularization
Tumours that are commonly
associated with arterio portal
fistula
§ HCC
§ Any tumour after percutaneous biopsy
§ And the most common is …..
Tumours that are commonly
associated with arterio portal
fistula
§ HCC
§ Any tumour after percutaneous biopsy
§ And the most common is ….. ANGIOMA
•  Up to 16% present with early
arterial enhancement
•  Usually small (less than 20 mm)
•  No wash out
•  Association with arterio-portal fistulae
•  Clue : plain MRI mainly T2 (+ no restriction)
Y menu difficult tumours of the liver jfim hanoi 2015

More Related Content

What's hot

Metastatic liver disease (2)
Metastatic liver disease (2)Metastatic liver disease (2)
Metastatic liver disease (2)
mostafa hegazy
 
Approach to liver mass (Cystic and Solid)
Approach to liver mass (Cystic and Solid)Approach to liver mass (Cystic and Solid)
Approach to liver mass (Cystic and Solid)
sauravmajumdar13
 
Liver neoplasms
Liver neoplasmsLiver neoplasms
Liver neoplasms
Amrut Basava
 
Liver tomour
Liver tomourLiver tomour
Liver tomour
syed ubaid
 
liver mass by atiq popal
liver mass by atiq popalliver mass by atiq popal
liver mass by atiq popal
Atiq Popal
 
Imaging of Malignant Liver Lesions
Imaging of Malignant Liver LesionsImaging of Malignant Liver Lesions
Imaging of Malignant Liver Lesions
Sahil Chaudhry
 
Focal hepatic lesions
Focal hepatic lesionsFocal hepatic lesions
Focal hepatic lesions
Yasser Asiri
 
Abdominal imaging hcc t loke
Abdominal imaging hcc t lokeAbdominal imaging hcc t loke
Abdominal imaging hcc t lokeJFIM
 
Liver lesions
Liver lesionsLiver lesions
Liver lesionsairwave12
 
Malignant liver lesions
Malignant liver lesionsMalignant liver lesions
Malignant liver lesions
Harshita Saxena
 
CT and MRI Imaging of Hepatic metastases
CT and MRI Imaging of Hepatic metastasesCT and MRI Imaging of Hepatic metastases
CT and MRI Imaging of Hepatic metastases
Dr Priyanka Vishwakarma
 
Focal malignant lesions of the liver.
Focal malignant lesions of the liver.Focal malignant lesions of the liver.
Focal malignant lesions of the liver.
Sanal Kumar
 
Ultrasonography of hepatic mass lesion
Ultrasonography of hepatic mass lesionUltrasonography of hepatic mass lesion
Ultrasonography of hepatic mass lesion
Abhilasha Singh
 
Liver specimen: Hepatocellular carcinoma, liver abscess
Liver specimen: Hepatocellular carcinoma, liver abscessLiver specimen: Hepatocellular carcinoma, liver abscess
Liver specimen: Hepatocellular carcinoma, liver abscess
Ankita Singh
 
Malignant liver masses
Malignant liver massesMalignant liver masses
Malignant liver masses
Anish Choudhary
 
Liver tumors [Benign and Malignant]
Liver tumors [Benign and Malignant]Liver tumors [Benign and Malignant]
Liver tumors [Benign and Malignant]
Karun Bhattarai
 

What's hot (20)

Metastatic liver disease (2)
Metastatic liver disease (2)Metastatic liver disease (2)
Metastatic liver disease (2)
 
Approach to liver mass (Cystic and Solid)
Approach to liver mass (Cystic and Solid)Approach to liver mass (Cystic and Solid)
Approach to liver mass (Cystic and Solid)
 
Liver neoplasms
Liver neoplasmsLiver neoplasms
Liver neoplasms
 
Liver tomour
Liver tomourLiver tomour
Liver tomour
 
liver mass by atiq popal
liver mass by atiq popalliver mass by atiq popal
liver mass by atiq popal
 
Imaging of Malignant Liver Lesions
Imaging of Malignant Liver LesionsImaging of Malignant Liver Lesions
Imaging of Malignant Liver Lesions
 
Focal hepatic lesions
Focal hepatic lesionsFocal hepatic lesions
Focal hepatic lesions
 
Abdominal imaging hcc t loke
Abdominal imaging hcc t lokeAbdominal imaging hcc t loke
Abdominal imaging hcc t loke
 
Liver lesions
Liver lesionsLiver lesions
Liver lesions
 
Malignant liver lesions
Malignant liver lesionsMalignant liver lesions
Malignant liver lesions
 
Liver Cancer Eng
Liver Cancer EngLiver Cancer Eng
Liver Cancer Eng
 
CT and MRI Imaging of Hepatic metastases
CT and MRI Imaging of Hepatic metastasesCT and MRI Imaging of Hepatic metastases
CT and MRI Imaging of Hepatic metastases
 
Liver Tumors
Liver TumorsLiver Tumors
Liver Tumors
 
Liver
LiverLiver
Liver
 
Focal malignant lesions of the liver.
Focal malignant lesions of the liver.Focal malignant lesions of the liver.
Focal malignant lesions of the liver.
 
Ultrasonography of hepatic mass lesion
Ultrasonography of hepatic mass lesionUltrasonography of hepatic mass lesion
Ultrasonography of hepatic mass lesion
 
Liver specimen: Hepatocellular carcinoma, liver abscess
Liver specimen: Hepatocellular carcinoma, liver abscessLiver specimen: Hepatocellular carcinoma, liver abscess
Liver specimen: Hepatocellular carcinoma, liver abscess
 
Malignant liver masses
Malignant liver massesMalignant liver masses
Malignant liver masses
 
Benign focal lesions in liver
Benign focal lesions in liverBenign focal lesions in liver
Benign focal lesions in liver
 
Liver tumors [Benign and Malignant]
Liver tumors [Benign and Malignant]Liver tumors [Benign and Malignant]
Liver tumors [Benign and Malignant]
 

Viewers also liked

Treatment of liver tumours current trends
Treatment of liver tumours current trendsTreatment of liver tumours current trends
Treatment of liver tumours current trends
Chandramohan K
 
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...Alejandro Garzón
 
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...ab medica
 
Model relacional i formes normals
Model relacional i formes normalsModel relacional i formes normals
Model relacional i formes normals
Miquel Boada Artigas
 
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
Gastrolearning
 
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Gastrolearning
 
Abdominal imaging ph cholangiok jm tubiana
Abdominal imaging ph cholangiok jm tubianaAbdominal imaging ph cholangiok jm tubiana
Abdominal imaging ph cholangiok jm tubianaJFIM
 
Evaluating Current Laparoscopic Applications In Surgery
Evaluating Current Laparoscopic Applications In SurgeryEvaluating Current Laparoscopic Applications In Surgery
Evaluating Current Laparoscopic Applications In SurgeryGeorge S. Ferzli
 
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MDMolecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
rick435
 
Hepatic & pancreatic tumors
Hepatic & pancreatic tumorsHepatic & pancreatic tumors
Hepatic & pancreatic tumors
ABDUL QADEER MEMON
 
LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
 LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
SHANTI MEMORIAL HOSPITAL PVT LTD
 
Gold Medal Teamwork with Mary Whipple
Gold Medal Teamwork with Mary WhippleGold Medal Teamwork with Mary Whipple
Gold Medal Teamwork with Mary Whipple
Spoken Communications
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
spa718
 
Determining resectability in pancreatic cancer
Determining resectability in pancreatic cancer Determining resectability in pancreatic cancer
Determining resectability in pancreatic cancer
harish Ys
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinoma
spa718
 
Git Endoscopic Ultrasound.
Git Endoscopic Ultrasound.Git Endoscopic Ultrasound.
Git Endoscopic Ultrasound.
Shaikhani.
 
liver tumours
liver tumoursliver tumours
Presentation1.pptx, radiological imaging of cholangiocarcinoma.
Presentation1.pptx, radiological imaging of cholangiocarcinoma.Presentation1.pptx, radiological imaging of cholangiocarcinoma.
Presentation1.pptx, radiological imaging of cholangiocarcinoma.Abdellah Nazeer
 

Viewers also liked (20)

Treatment of liver tumours current trends
Treatment of liver tumours current trendsTreatment of liver tumours current trends
Treatment of liver tumours current trends
 
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...
RESEARCHERS MAP SIGNIFICANT OF FUNCTIONAL SEQUENCES OF MOUSE GENOME AND ACTIV...
 
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...
P. Giulianotti - Robotics in General Surgery: State of Art and future perspec...
 
Model relacional i formes normals
Model relacional i formes normalsModel relacional i formes normals
Model relacional i formes normals
 
20
2020
20
 
Seminario Colangiocarcinoma
Seminario ColangiocarcinomaSeminario Colangiocarcinoma
Seminario Colangiocarcinoma
 
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
Il colangiocarcinoma: Presentazione Clinica, Diagnosi e Trattamento - Gastrol...
 
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
 
Abdominal imaging ph cholangiok jm tubiana
Abdominal imaging ph cholangiok jm tubianaAbdominal imaging ph cholangiok jm tubiana
Abdominal imaging ph cholangiok jm tubiana
 
Evaluating Current Laparoscopic Applications In Surgery
Evaluating Current Laparoscopic Applications In SurgeryEvaluating Current Laparoscopic Applications In Surgery
Evaluating Current Laparoscopic Applications In Surgery
 
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MDMolecular Profiling of Cholangiocarcinoma - Milind Javle, MD
Molecular Profiling of Cholangiocarcinoma - Milind Javle, MD
 
Hepatic & pancreatic tumors
Hepatic & pancreatic tumorsHepatic & pancreatic tumors
Hepatic & pancreatic tumors
 
LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
 LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
LAPAROSCOPIC SURGERY- PAST, PRESENT AND FUTURE
 
Gold Medal Teamwork with Mary Whipple
Gold Medal Teamwork with Mary WhippleGold Medal Teamwork with Mary Whipple
Gold Medal Teamwork with Mary Whipple
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
 
Determining resectability in pancreatic cancer
Determining resectability in pancreatic cancer Determining resectability in pancreatic cancer
Determining resectability in pancreatic cancer
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinoma
 
Git Endoscopic Ultrasound.
Git Endoscopic Ultrasound.Git Endoscopic Ultrasound.
Git Endoscopic Ultrasound.
 
liver tumours
liver tumoursliver tumours
liver tumours
 
Presentation1.pptx, radiological imaging of cholangiocarcinoma.
Presentation1.pptx, radiological imaging of cholangiocarcinoma.Presentation1.pptx, radiological imaging of cholangiocarcinoma.
Presentation1.pptx, radiological imaging of cholangiocarcinoma.
 

Similar to Y menu difficult tumours of the liver jfim hanoi 2015

Kidney and ureteric tumors
Kidney and ureteric tumorsKidney and ureteric tumors
Kidney and ureteric tumorsDr./ Ihab Samy
 
cystickidneydiseases-161210202710 (1).pdf
cystickidneydiseases-161210202710 (1).pdfcystickidneydiseases-161210202710 (1).pdf
cystickidneydiseases-161210202710 (1).pdf
HARYANVITRAVLLER
 
Cystic kidney diseases
Cystic kidney diseasesCystic kidney diseases
Cystic kidney diseases
sahar Hamdy
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
Deep Patel
 
Ascites park022310
Ascites park022310Ascites park022310
Ascites park022310Romy Bode
 
Gallbladder and Bile ducts Ultrasound
Gallbladder and Bile ducts Ultrasound Gallbladder and Bile ducts Ultrasound
Gallbladder and Bile ducts Ultrasound
Moses Hadid
 
Rcc and bladder cancer
Rcc and bladder cancerRcc and bladder cancer
Rcc and bladder cancer
Jwan AlSofi
 
Git j club colon ischemia.
Git j club colon ischemia.Git j club colon ischemia.
Git j club colon ischemia.
Shaikhani.
 
pancreatic cas managementby bedrumoh.pptx
pancreatic cas managementby bedrumoh.pptxpancreatic cas managementby bedrumoh.pptx
pancreatic cas managementby bedrumoh.pptx
Bedrumohammed2
 
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Gianfranco Tammaro
 
Gall bladder carcinoma.04
Gall bladder carcinoma.04Gall bladder carcinoma.04
Gall bladder carcinoma.04
Dr. ZAHID IQBAL MIR
 
Presentation 1.pptx
Presentation 1.pptxPresentation 1.pptx
Presentation 1.pptx
Bader27
 
Approac h to cholestatic jaundice
Approac h to cholestatic jaundiceApproac h to cholestatic jaundice
Approac h to cholestatic jaundice
Arun Karmakar
 
Focal liver lesions- in the eye of a radiologist
Focal liver lesions- in the eye of a radiologistFocal liver lesions- in the eye of a radiologist
Focal liver lesions- in the eye of a radiologist
Dr.Santosh Atreya
 
renaltumors upasana sahu Group 50.pptxism
renaltumors upasana sahu Group 50.pptxismrenaltumors upasana sahu Group 50.pptxism
renaltumors upasana sahu Group 50.pptxism
thxz2fdqxw
 
Budd chiary syndrome presentation latest.pptx
Budd chiary syndrome presentation latest.pptxBudd chiary syndrome presentation latest.pptx
Budd chiary syndrome presentation latest.pptx
katanchhabra
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
Arkaprovo Roy
 
Liver tumours.pptx
Liver tumours.pptxLiver tumours.pptx
Liver tumours.pptx
Pradeep Pande
 
Cystic liver disease
Cystic liver diseaseCystic liver disease
Cystic liver disease
LUMHS
 

Similar to Y menu difficult tumours of the liver jfim hanoi 2015 (20)

Kidney and ureteric tumors
Kidney and ureteric tumorsKidney and ureteric tumors
Kidney and ureteric tumors
 
cystickidneydiseases-161210202710 (1).pdf
cystickidneydiseases-161210202710 (1).pdfcystickidneydiseases-161210202710 (1).pdf
cystickidneydiseases-161210202710 (1).pdf
 
Cystic kidney diseases
Cystic kidney diseasesCystic kidney diseases
Cystic kidney diseases
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Ascites park022310
Ascites park022310Ascites park022310
Ascites park022310
 
Gallbladder and Bile ducts Ultrasound
Gallbladder and Bile ducts Ultrasound Gallbladder and Bile ducts Ultrasound
Gallbladder and Bile ducts Ultrasound
 
Rcc and bladder cancer
Rcc and bladder cancerRcc and bladder cancer
Rcc and bladder cancer
 
Git j club colon ischemia.
Git j club colon ischemia.Git j club colon ischemia.
Git j club colon ischemia.
 
pancreatic cas managementby bedrumoh.pptx
pancreatic cas managementby bedrumoh.pptxpancreatic cas managementby bedrumoh.pptx
pancreatic cas managementby bedrumoh.pptx
 
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
Anselmo A. Cirrosi Epatica e Tumori del Fegato: dalla Resezione al Trapianto....
 
Gall bladder carcinoma.04
Gall bladder carcinoma.04Gall bladder carcinoma.04
Gall bladder carcinoma.04
 
Presentation 1.pptx
Presentation 1.pptxPresentation 1.pptx
Presentation 1.pptx
 
Approac h to cholestatic jaundice
Approac h to cholestatic jaundiceApproac h to cholestatic jaundice
Approac h to cholestatic jaundice
 
Focal liver lesions- in the eye of a radiologist
Focal liver lesions- in the eye of a radiologistFocal liver lesions- in the eye of a radiologist
Focal liver lesions- in the eye of a radiologist
 
renaltumors upasana sahu Group 50.pptxism
renaltumors upasana sahu Group 50.pptxismrenaltumors upasana sahu Group 50.pptxism
renaltumors upasana sahu Group 50.pptxism
 
Rcc
RccRcc
Rcc
 
Budd chiary syndrome presentation latest.pptx
Budd chiary syndrome presentation latest.pptxBudd chiary syndrome presentation latest.pptx
Budd chiary syndrome presentation latest.pptx
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
 
Liver tumours.pptx
Liver tumours.pptxLiver tumours.pptx
Liver tumours.pptx
 
Cystic liver disease
Cystic liver diseaseCystic liver disease
Cystic liver disease
 

More from JFIM - Journées Francophones d'Imagerie Médicale

TRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
TRAUMATIC BRAIN INJURY - F. Benoudiba, JL SarrazinTRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
TRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
JFIM - Journées Francophones d'Imagerie Médicale
 
Acute Aortic Syndromes: Vascular Radiologist Point of View - Pr Ph Douek
Acute Aortic Syndromes:Vascular Radiologist Point of View - Pr Ph DouekAcute Aortic Syndromes:Vascular Radiologist Point of View - Pr Ph Douek
Acute Aortic Syndromes: Vascular Radiologist Point of View - Pr Ph Douek
JFIM - Journées Francophones d'Imagerie Médicale
 
Veinous thrombectomy new interventional technique - M.Cuinet
Veinous thrombectomy new interventional technique - M.Cuinet Veinous thrombectomy new interventional technique - M.Cuinet
Veinous thrombectomy new interventional technique - M.Cuinet
JFIM - Journées Francophones d'Imagerie Médicale
 
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERANDIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
JFIM - Journées Francophones d'Imagerie Médicale
 
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
JFIM - Journées Francophones d'Imagerie Médicale
 
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
JFIM - Journées Francophones d'Imagerie Médicale
 
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017 Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
JFIM - Journées Francophones d'Imagerie Médicale
 
Mehdi Cadi CT colonography Jfim Buenos-Aires 2017
Mehdi Cadi  CT colonography Jfim Buenos-Aires 2017Mehdi Cadi  CT colonography Jfim Buenos-Aires 2017
Mehdi Cadi CT colonography Jfim Buenos-Aires 2017
JFIM - Journées Francophones d'Imagerie Médicale
 
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Michel Correas, small renal tumors multiparametric characterization is t...
Jean Michel Correas, small renal tumors multiparametric characterization is t...Jean Michel Correas, small renal tumors multiparametric characterization is t...
Jean Michel Correas, small renal tumors multiparametric characterization is t...
JFIM - Journées Francophones d'Imagerie Médicale
 
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Yves Gauvrit, ASL - Arterial Spin Labeling, jfim ifupi milan 2018
Jean Yves Gauvrit, ASL - Arterial Spin Labeling,  jfim ifupi milan 2018Jean Yves Gauvrit, ASL - Arterial Spin Labeling,  jfim ifupi milan 2018
Jean Yves Gauvrit, ASL - Arterial Spin Labeling, jfim ifupi milan 2018
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
JFIM - Journées Francophones d'Imagerie Médicale
 
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
JFIM - Journées Francophones d'Imagerie Médicale
 
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
JFIM - Journées Francophones d'Imagerie Médicale
 
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
JFIM - Journées Francophones d'Imagerie Médicale
 
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Michel Correas, place and role of shear wave elastography for liver fibr...
Jean Michel Correas, place and role of shear wave elastography for liver fibr...Jean Michel Correas, place and role of shear wave elastography for liver fibr...
Jean Michel Correas, place and role of shear wave elastography for liver fibr...
JFIM - Journées Francophones d'Imagerie Médicale
 
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
JFIM - Journées Francophones d'Imagerie Médicale
 

More from JFIM - Journées Francophones d'Imagerie Médicale (20)

TRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
TRAUMATIC BRAIN INJURY - F. Benoudiba, JL SarrazinTRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
TRAUMATIC BRAIN INJURY - F. Benoudiba, JL Sarrazin
 
Acute Aortic Syndromes: Vascular Radiologist Point of View - Pr Ph Douek
Acute Aortic Syndromes:Vascular Radiologist Point of View - Pr Ph DouekAcute Aortic Syndromes:Vascular Radiologist Point of View - Pr Ph Douek
Acute Aortic Syndromes: Vascular Radiologist Point of View - Pr Ph Douek
 
Veinous thrombectomy new interventional technique - M.Cuinet
Veinous thrombectomy new interventional technique - M.Cuinet Veinous thrombectomy new interventional technique - M.Cuinet
Veinous thrombectomy new interventional technique - M.Cuinet
 
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERANDIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
DIAGNOSIS OF A CERVICAL TUMEFACTION - F HERAN
 
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
Françoise Heran Horner Syndrome, the essential, Jfim Buenos Aires 2017
 
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
Sophie Taieb How to avoid Errors in uterine imaging ? Jfim Buenos-Aires 2017
 
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017 Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
Matias Borensztein Thoracic biopsies and ablation, Jfim Buenos-Aires 2017
 
Mehdi Cadi CT colonography Jfim Buenos-Aires 2017
Mehdi Cadi  CT colonography Jfim Buenos-Aires 2017Mehdi Cadi  CT colonography Jfim Buenos-Aires 2017
Mehdi Cadi CT colonography Jfim Buenos-Aires 2017
 
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
Lionel Arrive, non contrast mr lymphography, jfim ifupi milan 2018
 
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
 
Jean Michel Correas, small renal tumors multiparametric characterization is t...
Jean Michel Correas, small renal tumors multiparametric characterization is t...Jean Michel Correas, small renal tumors multiparametric characterization is t...
Jean Michel Correas, small renal tumors multiparametric characterization is t...
 
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
Christine Hoeffel, update on imaging gastroenteropancreatic neuroendocrine tu...
 
Jean Yves Gauvrit, ASL - Arterial Spin Labeling, jfim ifupi milan 2018
Jean Yves Gauvrit, ASL - Arterial Spin Labeling,  jfim ifupi milan 2018Jean Yves Gauvrit, ASL - Arterial Spin Labeling,  jfim ifupi milan 2018
Jean Yves Gauvrit, ASL - Arterial Spin Labeling, jfim ifupi milan 2018
 
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
Jean Yves Gauvrit, Dementia daily exploration, jfim ifupi milan 2018
 
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
Mirko D'Onofrio, advanced multiparametric imaging in pancreas, jfim ifupi mil...
 
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
Gianpaolo Carrafiello, follow up after thermoablation therapy, jfim ifupi mil...
 
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
Giovanni Morana, diagnostic imaging of small hcc in liver cirrhosis, jfim ifu...
 
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
Luigi Grazioli, imaging following stereotactic radiotherapy in the liver, jfi...
 
Jean Michel Correas, place and role of shear wave elastography for liver fibr...
Jean Michel Correas, place and role of shear wave elastography for liver fibr...Jean Michel Correas, place and role of shear wave elastography for liver fibr...
Jean Michel Correas, place and role of shear wave elastography for liver fibr...
 
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
Jean Yves Gauvrit, gadolinium retention in the brain or other tissues jfim if...
 

Recently uploaded

The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

Y menu difficult tumours of the liver jfim hanoi 2015

  • 1. JFIM 2015 « Difficult » tumours of the Liver Yves Menu
  • 2. Is it… § The rare form of a common disease? § The common form of a rare disease ?
  • 8. Let’s adapt to modern Life Style
  • 9. Let’s adapt to modern Life Style LECTURE AVAILABLE HERE!
  • 10. The clue is elsewhere The Mixed Grill The Alien How to be brilliant Be patient How to look stupid Your best friend is…
  • 11. The Mixed-Grill § A 68 yo man, with metabolic chronic liver disease (NASH), A focal liver lesion is found at US. § CT is performed, with arterial and portal phase.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 53. What is the reason for asymetry of liver enhancement at the arterial phase ? 1.  Tumour angiogenesis increases regional perfusion («liver mismatch ») 2.  Hypoenhancement of the left lobe 3.  Portal flow problem 4.  Hepatic vein problem 5.  Arterialization of the right liver lobe, related to chronic liver disease
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105. According to mRECIST, in case of HCC, coeliac or mesenteric lymph node is a measurable target if its small axis is 1.  ≥ 10 mm 2.  ≥ 15 mm 3.  ≥ 20 mm 4.  ≥ 25 mm
  • 106. According to mRECIST, in case of HCC, porta hepatis lymph node is a measurable target if its small axis is 1.  ≥ 10 mm 2.  ≥ 15 mm 3.  ≥ 20 mm 4.  ≥ 25 mm
  • 107. Finally… § Ill-defined mass, with necrosis, portal vein invasion, satellite nodules and loco regional Lymph Nodes § In a patient with chronic liver disease
  • 108. Which is the tumour that never invades the portal vein? 1.  HCC 2.  Cholangiocarcinoma 3.  Liver Mets 4.  Neuroendocrine tumour 5.  Hepatocholangiocarcinoma
  • 109. Which is the tumour that never invades the portal vein? 1.  HCC 2.  Cholangiocarcinoma 3.  Liver Mets 4.  Neuroendocrine tumour 5.  Hepatocholangiocarcinoma
  • 110. The most likely diagnosis is HCC, however: § Total absence of hypervascularization § TIP : although 20% of HCC are hypovascular, they are usually not necrotic also § AFP basse Hypovascular + Necrosis + Cirrhosis = Weird !
  • 111. Strategy § Most likely diagnosis? §  HCC on cirrhosis § Which is the best treatment? §  Surgery § Is it possible? < Good status, no Portal Hypertension, left liver normal, no distant lesion = Infiltrating tumour, portal envasion, lymph nodes § Decision §  Right hepatectomy J30
  • 112. Hepato-Cholangiocarcinoma § Not so rare : 1-5 % of liver primary malignancies § H>F, chronic liver disease § Poor prognosis: 5-y survival 18-24%, including resected cases § Diagnosis mainly rely on histology and immunohistology §  Mucus + §  DesmoplasticStroma §  Fibrosis + nécrosis + haemorrhage §  CK7/CK19 + § The biopsy may miss the Cholangiocellular compartment
  • 114. Usual appearance of a rare tumour § In a patient with chronic liver disease, absence of hypervascularization associated to extensive necrosis would be unusual for HCC § Consider Heaptocholangiocarcinoma. Biopsy will not help
  • 115. The Alien.. § A 64 yo man, with end-stage HBV cirrhosis. During the pre transplantation staging, US finds a 30 mm hypoechoic mass § MRI is performed in order to characterize and stage
  • 116. T2 T1 FS T1 Arterial Phase DWI
  • 117. What is the most likely diagnosis? A.  Low grade Dysplastic Nodule B.  High grade Dysplastic Nodule C.  Regeneration Macronodule D.  HCC
  • 118. Nodule in the Nodule
  • 119. What is the most likely diagnosis? A.  Low grade Dysplastic Nodule B.  High grade Dysplastic Nodule C.  Regeneration Macronodule D.  HCC
  • 120. Dysplastic Nodules (DN) § Easy to recognize features §  Hyper T1 §  No fat §  Iso or Hypo T2 §  No arterial enhancement §  Precursor of HCC (high grade) § However §  Only the minority of DN’s are typical à iceberg syndrome §  HCC will come, but you don’t know where… § The Nodule-in-the-Nodule §  Famous and pathognomonic, but rare
  • 121. 2009
  • 122. 2009
  • 124. Be patient! § A 53 yo man comes with abnormal liver tests § Diagnosis of HCV is established §  US shows a large mass in the liver
  • 125.
  • 128.
  • 129. Liver contour Biopsy : -  Cirrhosis -  Adenocarcinoma most likely related to intestinal pimary cancer
  • 130. Cytokeratins (CK) CK7 - CK7 + CK20 - CK20 +
  • 132. Cytokeratin (CK) CK7 - CK7 + CK20 - HCC Cholangiocarcinoma CK20 + Colorectal Ca Pancreatic Ca In this patient: CK7+/CK20-
  • 133. Peripheral Cholangiocarcinoma (1 answer is correct): A.  Is more common on a cirrhotic liver B.  Usually comes with dilatation of bile ducts C.  Due to fibrous stroma (unlike HCC), capsular retraction and delayed enhancement are pathognomonic features.
  • 134. Peripheral Cholangiocarcinoma (1 answer is correct): A.  Is more common on a cirrhotic liver B.  Usually comes with dilatation of bile ducts C.  Due to fibrous stroma (unlike HCC), capsular retraction and delayed enhancement are pathognomonic features.
  • 135. Peripheral Cholangiocarcinoma (1 answer is correct): A.  Is more common on a cirrhotic liver B.  Usually comes with dilatation of bile ducts C.  Due to fibrous stroma (unlike HCC), capsular retraction and delayed enhancement are pathognomonic features.
  • 136. Cholangiocarcinoma (CC) §  Second more common liver primary malignancy §  Relative risk is x2 in cirrhotic patients §  Usual features are: §  Lobulated mass §  Hypodense centre (necrosis ou mucus) §  Mild arterial enhancement §  Late enhancement (fibrous compartment), non specific §  Capsular rretraction (20%, non specific) §  Bile ducts dilatation (20%) §  Curative treatment is surgery §  Standard CT is GEMOX (GEMcitabine + OXaliplatine) §  Poor prognosis in general, however, the doubling time has to be evaluated as prolonged survival (> 3 years) is sometimes observed In a cirrhotic patient, delayed enhancement is strongly in favour of a CCC, as HCC never presents with such a feature In a non – cirrhotic patient, be careful, as mets may have the same behaviour
  • 138. Your best friend is… § A 62 yo woman, with a previous liver transplantation, presents with abnormal liver tests. § MRI is performed to rule out biliary complication. § The radiologist report says that there is a « colon artefact within the liver »
  • 142. What is white on T1? § Fat § Blood § Proteins § And…. Fat Sat b=800
  • 143. Your best friend is … Ultrasound !
  • 144.
  • 145. Finally…. § Stones and calcifications are occasionnally white on T1
  • 146. 12 Days after OLT Plain Arterial Portal
  • 149. The clue is elsewhere § A 44 yo woman with severe bipolar disorder and recently discovered neurosarcoidosis. She is heavily depressed. § She complains of dyspnea and cough. Plain CT of the chest is performed in order to find pulmonary lesions, which is present. § An abnormality in the liver is found, and contrast enhanced images are obtained. There are no abdominal symptoms, liver tests are normal excepting for a mild increase of transaminases
  • 150.
  • 151.
  • 152.
  • 153.
  • 154. Summary § Multiple masses § Faintly vascular § In the context of sarcoidosis § However clinically asymptomatic
  • 155. Strategy § Rule out sarcoidosis (no spleen lesion, nodular liver lesions) § Further step(s) ? §  Biopsy à Denied by the patient §  PET-CT à Normal Something has to be done and it is free…
  • 156.
  • 157.
  • 158.
  • 159. 1 m after surgery 10 m after surgery
  • 160. Summary § Half of GastroEnteroPancreatic NeuroEndocrine Tumours (GEP-NET) are fortuitously discovered on imaging § Discordance between patient’s good condition and advanced imaging findings is a target sign § Don’t expect to rule out GEP-NET if not hypervascularized § FDG PET-CT might be negative in well-differentiated lesions (50%) § Don’t forget to look for « hidden areas » § DWI is usually the most powerful sequence for detection
  • 161. How to be brilliant… § A 75 YO man, with a cirrhosis on NASH. A nodule is found in the liver at Ultrasound
  • 162.
  • 163.
  • 164.
  • 165. Angiosarcoma § Liver angiosarcoma occurs mainly in the elder § Third most common primary liver maligancies § The prognosis of liver angiosarcoma is very poor with almost all patients with this kind of disease die within 2 years after diagnosis §  Early metastases to other organs, such as lung, spleen, or bone §  Severe intra-abdominal hemorrhage due to spontaneous rupture § Remember the dotted enhancement, translating “peliosis- like” blood-filled cavities
  • 166. How to look stupid § A 45 yo man with alcohol abuse and abnormal liver tests. US finds a hypoechic 2 cm mass in the right liver lobe
  • 168. Tumours that are commonly associated with arterio portal fistula § HCC § Any tumour after percutaneous biopsy § And the most common is …..
  • 169.
  • 170.
  • 171. Tumours that are commonly associated with arterio portal fistula § HCC § Any tumour after percutaneous biopsy § And the most common is ….. ANGIOMA •  Up to 16% present with early arterial enhancement •  Usually small (less than 20 mm) •  No wash out •  Association with arterio-portal fistulae •  Clue : plain MRI mainly T2 (+ no restriction)